Cuba produces Cholera Vaccine for 2015 release-GCSM President

Haleem-KhanGeorgetown: Cuba will release a new preventive vaccine against cholera in 2015, a state-owned pharmaceutical group who developing the drug announced recently, according to President of the Guyana Cuba Solidarity Movement (GCSM), Haleem Khan.

He explained that Cuban medical research continues to prove to be one of the most effective in the world.  It is guided by effective preventive approaches and not a pharmaceutical model that is profit-driven.

Khan underscored that Gustavo Sierra Gonzalez, the Vice President of the BioCubaFarma told the daily Juventud Rebelde that the clinical trials had been very successful, and that the proper health registration for the drug is expected to come next year.

Gonzalez said that the Cuban population would be vaccinated and that the drug would also be hand to the World Health Organization (WHO) for global use.  “Starting 2015, we will start protecting the whole population of the country and we are already prepared to increase its production to export it to other nations, including delivering it to the WHO,” he added.

Although a few cases of the disease were reported on the island, public health officials were able to control it rapidly and prevent its spread.

“Although the level of attention provided to those people who contracted the virus on the island makes it so that they practically do not run any risk because they are quickly treated, this illness can kill,” said Gonzalez.

Khan emphasised that the export of medicine and medical equipment represent about US$900M every year for the island, making it the second biggest export industry for Cuba after the nickel.

The Cuba Solidarity President elaborated that Cuban medical research has already developed four vaccines, including a vaccine against advanced lung cancer developed in 2012 with clinical tests carried out in over 80 countries. Although the drug does not cure cancer, the tumors have been found to reduce in size, improving the health and life expectancy of the patients.

The Molecular Immunology Center, located in Havana, also created the Meningitis-B vaccine in 1985, as well as for Hepatitis-B and Dengue later on.